Insulin users would pay no deductible and cap out-of-pocket costs at the lesser of $35 per month or 25% of the negotiated price for selected products.
This bill would make insulin more affordable for many Americans starting in 2026. It would stop health plans from charging a deductible for selected insulin products. It would also cap monthly out-of-pocket costs for these products at $35 or 25% of the negotiated price, whichever is less.
Today, many health plans can charge deductibles for insulin and have no federal cap on monthly out-of-pocket costs. If this bill becomes law, starting January 1, 2026, most health plans would not be able to charge a deductible for selected insulin products. Monthly out-of-pocket costs for these products would be capped at the lesser of $35 per 30-day supply or 25% of the negotiated price.
HR 6255 · 119th Congress · November 21, 2025 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
1 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.